(Date:11/27/2009)...ELOWNA, BC, Nov. 27 /PRNewswire/ - Uploadable USB ...prime time in wellness. A combination of advanced ...oad are solving a long term concern over the accur...curately gauge and reward improved participation i... is one of the first wellness suppliers to integra...
(Date:11/27/2009)...AN FRANCISCO, Nov. 27 Th...that Blair Lambert, CFO/COO, will present at the N...d at the May Fair Hotel in London, England, on Wed... To listen to a live broadcast of The Gymboree Cor...log on to www.gymboree.com, click on "Our Company"...
(Date:11/27/2009)...IBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-FirstCa... ) ( "Shamir" ), a leading provider of innovative ...ket, announced today that its board of directors h...e amount of US$ 10 million (approximately NIS 37.6...ative rate of exchange), or approximately US$ 0.60...
(Date:11/27/2009)...s to bring unprecedented medical, economic burdens...althDay News) -- The number of people with diabete...the next 25 years, a new study predicts. , That...on people with the disease, up from 23.7 million t... people with diabetes will triple, the study also ...
(Date:11/27/2009)... Multi-purpose bilingual coloring boo...r use by the business community to educate - infor...cts from Safety issues to Dinosuars to ABC,S and a...Saint Louis, MO (PRWEB) November 27, 2009 -- Today... or toys to keep them busy any hour of the day, bu...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2... published in the June 6 issue of JAMA, has identi...diffuse gastric cancer. It states that these muta...s and common ancestry. The study has been released...on in the article, gastric cancer is the second mo...
... According to a University of Pittsburgh Medical C... of the American Society of Clinical Oncology (ASC...he ASCO proceedings, patients treated for follicul...udy patients responded completely to the treatment...
...esys, Inc. (Nasdaq: CEGE) today announced follow-u...otherapy for pancreatic cancer which was conducted... The trial enrolled 60 patients with operable pan...e patients was previously reported to be 26.8 mont...
...does upset those at the receiving end, even if it ...ghts and ambiguous remarks that are hard to pin do...discrimination, according to a study of 180 Korean... of depression and anxiety," said lead author Samu...
...ON, D.C. At the 54th Annual Meeting of SNM, the wo...clear medicine professionals, German researchers ...emission tomography (PET), accurately identifies p...nt to clinical decision making in the treatment of...
...ON, HHS Secretary Mike Leavitt announced today tha...avarian Nordic A/S of Copenhagen, Denmark to manu...eration modified vaccinia Ankara (MVA) smallpox va...stems. The full supply of the vaccine will be adde...
Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Esophageal Cancer Patients' Positive Responses to Chemotherapy Accurately Identified by PET 2Health News:HHS Buys Next Generation Smallpox Vaccine 2Health News:HHS Buys Next Generation Smallpox Vaccine 3(Date:11/26/2009)...HANNESBURG, South Africa, Nov. 26 ... of the Year Award in the Generic Pharmaceutical M...mited. ,, (Logo: http://www.newscom.com/cgi-bi...the Year Award, the following criteria were used t... competitors: growth strategy and implementation, ...
(Date:11/25/2009)...ETON, N.J., Nov. 25 Phar...armaceutical company committed to discovering, dev...iral infections, reported financial results for th...er 30, 2009 Pharmasset held $58.4 million in cash,..., Pipeline Update and 2009 Highlights ,, RG...
(Date:11/25/2009)... PALM BEACH, Fla., Nov. 25 /PRNewswire-FirstCall/ ...ericans, especially the 27 million living with unt... that happy, says audiologist Cindy Beyer. ,, D... EAR ), one of America,s largest hearing care and ... hearing loss to stress, frustration, and social i...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 1Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 2Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 3QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 1QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 2QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 3QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 4QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 5QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 6AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 1AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 2AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 3AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 4AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 5...ation aimed at enabling vaccine production facilit...itional egg-based facility., * Once established, ...of, pandemic flu vaccine to commence within 12 we...ngland and ROCKVILLE, Md., Dec. 10, GE Healthcare,...and Novavax Inc. (Nasdaq: NVAX ), today announced...
...ec. 10 Exelixis, Inc. (Nasdaq:,EXEL), today repor...XL019,in patients with myelofibrosis, a myeloproli...al small molecule that selectively inhibits the ty... activated in response to,cytokines and hematopoie...ted in the majority of MPD patients and is deregul...
Other Medicine Technology:GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 2GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 3GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 4Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 2Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 3Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 4...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: